Challenges in identifying mRNA transcript starts and ends from long-read sequencing data
Genome Research · 2024-11 · 34 (11) · 1719-1734
DOI: 10.1101/gr.279559.124 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Genome Research, online erschienen am 20.11.2024. Verfasst von Ezequiel Calvo-Roitberg und 2 weiteren Autor:innen. Beteiligte Einrichtung: RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, Massachusetts 01605, USA. Hauptthemen laut MEDLINE: RNA, Messenger, Sequence Analysis, RNA. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 154 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHGRI NIH HHS, NIAID NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
Long-read sequencing (LRS) technologies have the potential to revolutionize scientific discoveries in RNA biology through the comprehensive identification and quantification of full-length mRNA isoforms. Despite great promise, challenges remain in the widespread implementation of LRS technologies for RNA-based applications, including concerns about low coverage, high sequencing error, and robust computational pipelines. Although much focus has been placed on defining mRNA exon composition and structure with LRS data, less careful characterization has been done of the ability to assess the terminal ends of isoforms, specifically, transcription start and end sites. Such characterization is crucial for completely delineating full mRNA molecules and regulatory consequences. However, there are substantial inconsistencies in both start and end coordinates of LRS reads spanning a gene, such that LRS reads often fail to accurately recapitulate annotated or empirically derived terminal ends of mRNA molecules. Here, we describe the specific challenges of identifying and quantifying mRNA terminal ends with LRS technologies and how these issues influence biological interpretations of LRS data. We then review recent experimental and computational advances designed to alleviate these problems, with ideal use cases for each approach. Finally, we outline anticipated developments and necessary improvements for the characterization of terminal ends from LRS data.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, Massachusetts 01605, USA.
- RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, Massachusetts 01605, USA athma.pai@umassmed.edu.
ORCID-Profile: Ezequiel Calvo-Roitberg, Rachel F Daniels, Athma A Pai
Förderung
- NHGRI NIH HHS
- NIAID NIH HHS
- NIGMS NIH HHS
- National Institute of General Medical Sciences
- National Human Genome Research Institute
- National Institute of Allergy and Infectious Diseases
Zitieren
APA
Calvo-Roitberg, E., Daniels, R. F., & Pai, A. A. (2024). Challenges in identifying mRNA transcript starts and ends from long-read sequencing data. Genome Research, 34(11), 1719-1734. https://doi.org/10.1101/gr.279559.124
Vancouver
Calvo-Roitberg E, Daniels RF, Pai AA. Challenges in identifying mRNA transcript starts and ends from long-read sequencing data. Genome Research. 2024;34(11):1719-1734. doi:10.1101/gr.279559.124
BibTeX
@article{CalvoRoitberg2024,
author = {Calvo-Roitberg, Ezequiel and Daniels, Rachel F and Pai, Athma A},
title = {Challenges in identifying mRNA transcript starts and ends from long-read sequencing data},
journal = {Genome Research},
year = {2024},
volume = {34},
number = {11},
pages = {1719--1734},
doi = {10.1101/gr.279559.124}
}
EUVIMED